321 related articles for article (PubMed ID: 18676329)
1. Cardiovascular toxicity associated with cancer treatment.
Viale PH; Yamamoto DS
Clin J Oncol Nurs; 2008 Aug; 12(4):627-38. PubMed ID: 18676329
[TBL] [Abstract][Full Text] [Related]
2. What kind of rash is it?: deciphering the dermatologic toxicities of biologic and targeted therapies.
Esper P; Gale D; Muehlbauer P
Clin J Oncol Nurs; 2007 Oct; 11(5):659-66. PubMed ID: 17962174
[TBL] [Abstract][Full Text] [Related]
3. Concurrent therapies that protect against doxorubicin-induced cardiomyopathy.
Simpson C; Herr H; Courville KA
Clin J Oncol Nurs; 2004 Oct; 8(5):497-501. PubMed ID: 15515283
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma and treatment-related thromboembolism: oncology nurses' role in prevention, assessment, and diagnosis.
Wiley KE
Clin J Oncol Nurs; 2007 Dec; 11(6):847-51. PubMed ID: 18063543
[TBL] [Abstract][Full Text] [Related]
5. [The cardiac toxicity of cancer chemotherapy].
Sequeira JF; Madruga IM; Ribeiro M; Duarte PC; Ferreira DC; Sarmento JL
Acta Med Port; 1994 May; 7(5):311-8. PubMed ID: 8073908
[TBL] [Abstract][Full Text] [Related]
6. Infusion reactions triggered by monoclonal antibodies treating solid tumors.
Carney PH; Ollom CL
J Infus Nurs; 2008; 31(2):74-83. PubMed ID: 18344767
[TBL] [Abstract][Full Text] [Related]
7. [Cardiotoxicity of drugs used in oncology].
Poprach A; Petráková K; Vyskocil J; Lakomý R; Nemecek R; Kocák I; Kocáková I; Vyzula R
Klin Onkol; 2008; 21(5):288-93. PubMed ID: 19202960
[TBL] [Abstract][Full Text] [Related]
8. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.
Webster-Gandy JD; How C; Harrold K
Eur J Oncol Nurs; 2007 Jul; 11(3):238-46. PubMed ID: 17350337
[TBL] [Abstract][Full Text] [Related]
9. Cardiac toxicity related to cancer treatment.
Loerzel VW; Dow KH
Clin J Oncol Nurs; 2003; 7(5):557-62. PubMed ID: 14603553
[TBL] [Abstract][Full Text] [Related]
10. Managing hematologic toxicities in the oncology patient.
Montoya L
J Infus Nurs; 2007; 30(3):168-72. PubMed ID: 17505218
[TBL] [Abstract][Full Text] [Related]
11. Clinical practice guidelines for the use of colony-stimulating factors in cancer treatment: Implications for oncology nurses.
Kearney N; Friese C
Eur J Oncol Nurs; 2008 Feb; 12(1):14-25. PubMed ID: 18291720
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and management of peripheral neuropathy in diabetic patients with cancer.
Visovsky C; Meyer RR; Roller J; Poppas M
Clin J Oncol Nurs; 2008 Apr; 12(2):243-7. PubMed ID: 18390460
[TBL] [Abstract][Full Text] [Related]
13. Targeted cancer. These "smart weapons" hit cancer in novel ways.
Held-Warmkessel J
Nursing; 2008 Sep; 38(9):26-32. PubMed ID: 18719487
[TBL] [Abstract][Full Text] [Related]
14. A historical perspective of anthracycline cardiotoxicity.
Ewer MS; Von Hoff DD; Benjamin RS
Heart Fail Clin; 2011 Jul; 7(3):363-72. PubMed ID: 21749888
[TBL] [Abstract][Full Text] [Related]
15. Managing drug infusion reactions: focus on cetuximab monoclonal antibody therapy.
Wilkes G
Clin J Oncol Nurs; 2008 Jun; 12(3):530-2. PubMed ID: 18515254
[No Abstract] [Full Text] [Related]
16. Prevention and management of cardiotoxicity from antineoplastic therapy.
Chanan-Khan A; Srinivasan S; Czuczman MS
J Support Oncol; 2004; 2(3):251-6; discussion 259-61, 264-6. PubMed ID: 15328825
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous reactions associated with alpha interferon therapy.
Stafford-Fox V; Guindon KM
Clin J Oncol Nurs; 2000; 4(4):164-8. PubMed ID: 11261097
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
Yeh ET; Tong AT; Lenihan DJ; Yusuf SW; Swafford J; Champion C; Durand JB; Gibbs H; Zafarmand AA; Ewer MS
Circulation; 2004 Jun; 109(25):3122-31. PubMed ID: 15226229
[TBL] [Abstract][Full Text] [Related]
19. Cardiotoxicity of cancer therapy.
Floyd JD; Nguyen DT; Lobins RL; Bashir Q; Doll DC; Perry MC
J Clin Oncol; 2005 Oct; 23(30):7685-96. PubMed ID: 16234530
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapies in breast cancer: challenging questions from oncology nurses.
Becze E
ONS Connect; 2007; 22(8 Suppl):31-2. PubMed ID: 17824554
[No Abstract] [Full Text] [Related]
[Next] [New Search]
